A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese Participants
Clinical trial NCT06476821 · COMPLETED
Trial details
- NCT number
- NCT06476821
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-27
- Primary completion
- 2024-10-11
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.